Issued Patents 2017
Showing 1–7 of 7 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9783591 | Use of the CD2 signaling domain in second-generation chimeric antigen receptors | John Scholler, Avery D. Posey | 2017-10-10 |
| 9765156 | Enhancing activity of CAR T cells by co-introducing a bispecific antibody | Yangbing Zhao, Xiaojun Liu | 2017-09-19 |
| 9714278 | Use of ICOS-based CARs to enhance antitumor activity and CAR persistence | Sonia Guedan Carrio, Yangbing Zhao, John Scholler | 2017-07-25 |
| 9573988 | Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells | Jennifer Brogdon, Saar Gill, Michael D. Kalos, Andreas Loew, John Scholler | 2017-02-21 |
| 9572836 | Methods for assessing the suitability of transduced T cells for administration | Bruce L. Levine, Michael D. Kalos | 2017-02-21 |
| 9555105 | Artificial antigen presenting cells and uses thereof | James L. Riley, Robert Vonderheide, Nicole Aqui, Megan Davis | 2017-01-31 |
| 9540445 | Compositions and methods for treatment of cancer | Bruce L. Levine, David L. Porter, Michael D. Kalos, Michael C. Milone | 2017-01-10 |